Archive of stories published by Amplitude VC

Homepage

Open in app

Amplitude VC

All

Amplitude Ventures in Amplitude VC

Jun 23, 2020

Why Repare Therapeutics could be a game-changing biotech company

Amplitude Ventures in Amplitude VC

Nov 6, 2019

Introduction to Amplitude Ventures

We’re here! We are excited to announce the launch of a new $200M Canadian- focused, healthcare…

Amplitude Ventures in Amplitude VC

Feb 10, 2021

Deep Genomics: how the combination of precision medicine and AI is revolutionizing drug discovery

Amplitude Ventures in Amplitude VC

Jan 31, 2022

Gandeeva Therapeutics — unlocking the power of cryo-EM

Amplitude Ventures in Amplitude VC

Dec 15, 2021

Valence: creating a world-leading AI chemistry design company

Amplitude Ventures in Amplitude VC

Mar 28, 2022

Celsius Therapeutics: Bringing Further Precision to Precision Medicine — the Promise of Single-Cell Sequencing

Amplitude Ventures in Amplitude VC

Nov 3, 2021

Prilenia: a potential new treatment for Huntington’s Disease & ALS

These were the top 10 stories published by Amplitude VC; you can also dive into yearly archives: 2019, 2020, 2021, and 2022.

About

Amplitude VC

New Canadian VC investing in precision medicine

More information

Why Repare Therapeutics could be a game-changing biotech company

Introduction to Amplitude Ventures

Notch Therapeutics: Solving the Big Issues in Cell Therapy

Congruence Therapeutics — The AI platform targeting protein misfolding

RNA therapeutics for rare diseases — our investment in Deep Genomics

Deep Genomics: how the combination of precision medicine and AI is revolutionizing drug discovery

Gandeeva Therapeutics — unlocking the power of cryo-EM

Valence: creating a world-leading AI chemistry design company

Celsius Therapeutics: Bringing Further Precision to Precision Medicine — the Promise of Single-Cell Sequencing

Prilenia: a potential new treatment for Huntington’s Disease & ALS